Global Anthrax Vaccines Market Research Report 2023(Status and Outlook)

Global Anthrax Vaccines Market Research Report 2023(Status and Outlook)



Report Overview

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.

North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.

In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.

The Global Anthrax Vaccines Market Size was estimated at USD 612 million in 2022 and is projected to reach USD 1021.97 million by 2029, exhibiting a CAGR of 7.60% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Anthrax Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anthrax Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anthrax Vaccines market in any manner.

Global Anthrax Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Emergent BioSolutions

Merial

Merck

Zoetis

Bayer Sanidad Animal

Colorado Serum

PharmAthene

Tiankang

Biogénesis-Bago

CAVAC

Rosenbusch

Agrovet

Vecol

CVCRI

IVPM

Prondil

CDV

Indian Immunologicals

Botswana Vaccine Institute

Ceva Santé Animale

Intervac

JOVAC

Market Segmentation (by Type)

Live Vaccines

Cell free PA Vaccines

Market Segmentation (by Application)

Passenger Car

Commercial Vehicle

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Anthrax Vaccines Market

Overview of the regional outlook of the Anthrax Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anthrax Vaccines
1.2 Key Market Segments
1.2.1 Anthrax Vaccines Segment by Type
1.2.2 Anthrax Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anthrax Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Anthrax Vaccines Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Anthrax Vaccines Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anthrax Vaccines Market Competitive Landscape
3.1 Global Anthrax Vaccines Sales by Manufacturers (2018-2023)
3.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.3 Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anthrax Vaccines Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Anthrax Vaccines Sales Sites, Area Served, Product Type
3.6 Anthrax Vaccines Market Competitive Situation and Trends
3.6.1 Anthrax Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anthrax Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anthrax Vaccines Industry Chain Analysis
4.1 Anthrax Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anthrax Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anthrax Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anthrax Vaccines Sales Market Share by Type (2018-2023)
6.3 Global Anthrax Vaccines Market Size Market Share by Type (2018-2023)
6.4 Global Anthrax Vaccines Price by Type (2018-2023)
7 Anthrax Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anthrax Vaccines Market Sales by Application (2018-2023)
7.3 Global Anthrax Vaccines Market Size (M USD) by Application (2018-2023)
7.4 Global Anthrax Vaccines Sales Growth Rate by Application (2018-2023)
8 Anthrax Vaccines Market Segmentation by Region
8.1 Global Anthrax Vaccines Sales by Region
8.1.1 Global Anthrax Vaccines Sales by Region
8.1.2 Global Anthrax Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Anthrax Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anthrax Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anthrax Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anthrax Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anthrax Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Emergent BioSolutions
9.1.1 Emergent BioSolutions Anthrax Vaccines Basic Information
9.1.2 Emergent BioSolutions Anthrax Vaccines Product Overview
9.1.3 Emergent BioSolutions Anthrax Vaccines Product Market Performance
9.1.4 Emergent BioSolutions Business Overview
9.1.5 Emergent BioSolutions Anthrax Vaccines SWOT Analysis
9.1.6 Emergent BioSolutions Recent Developments
9.2 Merial
9.2.1 Merial Anthrax Vaccines Basic Information
9.2.2 Merial Anthrax Vaccines Product Overview
9.2.3 Merial Anthrax Vaccines Product Market Performance
9.2.4 Merial Business Overview
9.2.5 Merial Anthrax Vaccines SWOT Analysis
9.2.6 Merial Recent Developments
9.3 Merck
9.3.1 Merck Anthrax Vaccines Basic Information
9.3.2 Merck Anthrax Vaccines Product Overview
9.3.3 Merck Anthrax Vaccines Product Market Performance
9.3.4 Merck Business Overview
9.3.5 Merck Anthrax Vaccines SWOT Analysis
9.3.6 Merck Recent Developments
9.4 Zoetis
9.4.1 Zoetis Anthrax Vaccines Basic Information
9.4.2 Zoetis Anthrax Vaccines Product Overview
9.4.3 Zoetis Anthrax Vaccines Product Market Performance
9.4.4 Zoetis Business Overview
9.4.5 Zoetis Anthrax Vaccines SWOT Analysis
9.4.6 Zoetis Recent Developments
9.5 Bayer Sanidad Animal
9.5.1 Bayer Sanidad Animal Anthrax Vaccines Basic Information
9.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Overview
9.5.3 Bayer Sanidad Animal Anthrax Vaccines Product Market Performance
9.5.4 Bayer Sanidad Animal Business Overview
9.5.5 Bayer Sanidad Animal Anthrax Vaccines SWOT Analysis
9.5.6 Bayer Sanidad Animal Recent Developments
9.6 Colorado Serum
9.6.1 Colorado Serum Anthrax Vaccines Basic Information
9.6.2 Colorado Serum Anthrax Vaccines Product Overview
9.6.3 Colorado Serum Anthrax Vaccines Product Market Performance
9.6.4 Colorado Serum Business Overview
9.6.5 Colorado Serum Recent Developments
9.7 PharmAthene
9.7.1 PharmAthene Anthrax Vaccines Basic Information
9.7.2 PharmAthene Anthrax Vaccines Product Overview
9.7.3 PharmAthene Anthrax Vaccines Product Market Performance
9.7.4 PharmAthene Business Overview
9.7.5 PharmAthene Recent Developments
9.8 Tiankang
9.8.1 Tiankang Anthrax Vaccines Basic Information
9.8.2 Tiankang Anthrax Vaccines Product Overview
9.8.3 Tiankang Anthrax Vaccines Product Market Performance
9.8.4 Tiankang Business Overview
9.8.5 Tiankang Recent Developments
9.9 Biogénesis-Bago
9.9.1 Biogénesis-Bago Anthrax Vaccines Basic Information
9.9.2 Biogénesis-Bago Anthrax Vaccines Product Overview
9.9.3 Biogénesis-Bago Anthrax Vaccines Product Market Performance
9.9.4 Biogénesis-Bago Business Overview
9.9.5 Biogénesis-Bago Recent Developments
9.10 CAVAC
9.10.1 CAVAC Anthrax Vaccines Basic Information
9.10.2 CAVAC Anthrax Vaccines Product Overview
9.10.3 CAVAC Anthrax Vaccines Product Market Performance
9.10.4 CAVAC Business Overview
9.10.5 CAVAC Recent Developments
9.11 Rosenbusch
9.11.1 Rosenbusch Anthrax Vaccines Basic Information
9.11.2 Rosenbusch Anthrax Vaccines Product Overview
9.11.3 Rosenbusch Anthrax Vaccines Product Market Performance
9.11.4 Rosenbusch Business Overview
9.11.5 Rosenbusch Recent Developments
9.12 Agrovet
9.12.1 Agrovet Anthrax Vaccines Basic Information
9.12.2 Agrovet Anthrax Vaccines Product Overview
9.12.3 Agrovet Anthrax Vaccines Product Market Performance
9.12.4 Agrovet Business Overview
9.12.5 Agrovet Recent Developments
9.13 Vecol
9.13.1 Vecol Anthrax Vaccines Basic Information
9.13.2 Vecol Anthrax Vaccines Product Overview
9.13.3 Vecol Anthrax Vaccines Product Market Performance
9.13.4 Vecol Business Overview
9.13.5 Vecol Recent Developments
9.14 CVCRI
9.14.1 CVCRI Anthrax Vaccines Basic Information
9.14.2 CVCRI Anthrax Vaccines Product Overview
9.14.3 CVCRI Anthrax Vaccines Product Market Performance
9.14.4 CVCRI Business Overview
9.14.5 CVCRI Recent Developments
9.15 IVPM
9.15.1 IVPM Anthrax Vaccines Basic Information
9.15.2 IVPM Anthrax Vaccines Product Overview
9.15.3 IVPM Anthrax Vaccines Product Market Performance
9.15.4 IVPM Business Overview
9.15.5 IVPM Recent Developments
9.16 Prondil
9.16.1 Prondil Anthrax Vaccines Basic Information
9.16.2 Prondil Anthrax Vaccines Product Overview
9.16.3 Prondil Anthrax Vaccines Product Market Performance
9.16.4 Prondil Business Overview
9.16.5 Prondil Recent Developments
9.17 CDV
9.17.1 CDV Anthrax Vaccines Basic Information
9.17.2 CDV Anthrax Vaccines Product Overview
9.17.3 CDV Anthrax Vaccines Product Market Performance
9.17.4 CDV Business Overview
9.17.5 CDV Recent Developments
9.18 Indian Immunologicals
9.18.1 Indian Immunologicals Anthrax Vaccines Basic Information
9.18.2 Indian Immunologicals Anthrax Vaccines Product Overview
9.18.3 Indian Immunologicals Anthrax Vaccines Product Market Performance
9.18.4 Indian Immunologicals Business Overview
9.18.5 Indian Immunologicals Recent Developments
9.19 Botswana Vaccine Institute
9.19.1 Botswana Vaccine Institute Anthrax Vaccines Basic Information
9.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Overview
9.19.3 Botswana Vaccine Institute Anthrax Vaccines Product Market Performance
9.19.4 Botswana Vaccine Institute Business Overview
9.19.5 Botswana Vaccine Institute Recent Developments
9.20 Ceva Santé Animale
9.20.1 Ceva Santé Animale Anthrax Vaccines Basic Information
9.20.2 Ceva Santé Animale Anthrax Vaccines Product Overview
9.20.3 Ceva Santé Animale Anthrax Vaccines Product Market Performance
9.20.4 Ceva Santé Animale Business Overview
9.20.5 Ceva Santé Animale Recent Developments
9.21 Intervac
9.21.1 Intervac Anthrax Vaccines Basic Information
9.21.2 Intervac Anthrax Vaccines Product Overview
9.21.3 Intervac Anthrax Vaccines Product Market Performance
9.21.4 Intervac Business Overview
9.21.5 Intervac Recent Developments
9.22 JOVAC
9.22.1 JOVAC Anthrax Vaccines Basic Information
9.22.2 JOVAC Anthrax Vaccines Product Overview
9.22.3 JOVAC Anthrax Vaccines Product Market Performance
9.22.4 JOVAC Business Overview
9.22.5 JOVAC Recent Developments
10 Anthrax Vaccines Market Forecast by Region
10.1 Global Anthrax Vaccines Market Size Forecast
10.2 Global Anthrax Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anthrax Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Anthrax Vaccines Market Size Forecast by Region
10.2.4 South America Anthrax Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anthrax Vaccines by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Anthrax Vaccines Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Anthrax Vaccines by Type (2024-2029)
11.1.2 Global Anthrax Vaccines Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Anthrax Vaccines by Type (2024-2029)
11.2 Global Anthrax Vaccines Market Forecast by Application (2024-2029)
11.2.1 Global Anthrax Vaccines Sales (K MT) Forecast by Application
11.2.2 Global Anthrax Vaccines Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings